KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

A Problematic Biomarker Trial Design.

Boris Freidlin, Edward L Korn

J Natl Cancer Inst 114(2) 187-190

PMID34289052
PMCIDPMC8826527
DOI10.1093/jnci/djab144
发表日期2021-07-21
摘要

摘要

Efficient biomarker-driven randomized clinical trials are a key tool for implementing precision oncology. A commonly used biomarker phase III design is focused on testing the treatment effect in biomarker-positive and overall study populations. This approach may result in recommending new treatments to biomarker-negative patients when these treatments have no benefit for these patients.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。